Cholesin receptor signalling is active in cardiovascular system-associated adipose tissue and correlates with SGLT2i treatment in patients with diabetes.
膽固醇受體信號在心血管系統相關的脂肪組織中活躍,並與糖尿病患者的SGLT2i治療相關。
Cardiovasc Diabetol 2024-06-20
Biomolecules of Adipose Tissue in Atherosclerotic Plaques of Men With Coronary Atherosclerosis.
冠狀動脈動脈粥樣硬化男性的動脈粥樣硬化斑塊中的脂肪組織生物分子。
Kardiologiia 2024-09-12
Genetic Evidence for GLP-1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH.
GLP-1 和 GIP 受體作為 MASLD/MASH 治療和預防目標的遺傳證據。
Liver Int 2024-11-02
Adiponectin may play a crucial role in the metabolic effects of GLP-1RAs treatment in patients with Type 2 Diabetes Mellitus: a preliminary longitudinal study.
Adiponectin 可能在 2 型糖尿病患者接受 GLP-1RAs 治療的代謝效應中扮演關鍵角色:一項初步的縱向研究。
Endocrine 2024-11-09
G protein-coupled receptor 17 inhibits glucagon-like peptide-1 secretion via a Gi/o-dependent mechanism in enteroendocrine cells.
G 蛋白偶聯受體 17 透過 Gi/o 依賴性機制抑制腸內分泌細胞中胰高血糖素樣肽-1 的分泌。
bioRxiv 2024-11-28
G Protein-Coupled Receptor 17 Inhibits Glucagon-like Peptide-1 Secretion via a Gi/o-Dependent Mechanism in Enteroendocrine Cells.
G 蛋白偶聯受體 17 透過 Gi/o 依賴機制抑制腸內分泌細胞中的胰高血糖素樣肽-1 分泌。
Biomolecules 2025-01-25
Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity.
人類脂肪組織脂解的荷爾蒙調控:脂肪組織 GIP 系統在超重和肥胖中的影響。
Eur J Endocrinol 2025-02-12